Home insulin pump use feasible for hospitalised children with type 1 diabetes
For children with type 1 diabetes who are admitted to hospital, continuing with a home insulin pump is feasible for the prevention of hyperglycemia and hypoglycemia, suggests research published in JAMA Network Open.
Rationale for antiviral therapy in new-onset type 1 diabetes
Antiviral therapy may preserve residual insulin production in children and adolescents newly diagnosed with type 1 diabetes, suggest findings from the DiViD intervention study.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Mild gestational glucose intolerance tied to future type 2 diabetes risk
Impaired glucose tolerance during pregnancy that does not meet the criteria for gestational diabetes nevertheless increases the likelihood that women will later develop type 2 diabetes, a study shows.
Health informatics system aids timely, equitable diabetes care
A health informatics system based on routine clinical data helps physicians to prioritize high-risk people with diabetes, deliver more equitable care, and manage healthcare capacity, report researchers.
Obesity as prevalent in type 1 diabetes as general US population
There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.
TriMaster data support ‘try before you choose’ for type 2 diabetes medications
Allowing people to trial medications for type 2 diabetes and choose their preferred one is a viable approach in the absence of a clear clinical indication.
Meta-analysis backs SGLT2 inhibitors for kidney disease
A meta-analysis published in The Lancet supports the use of SGLT2 inhibitors in people with chronic kidney disease, irrespective of whether they have type 2 diabetes.
Real-world adjunctive medication outcomes in type 1 diabetes revealed
People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.
Diabetes ‘no longer a CVD risk equivalent’
The strength of the association between diabetes and the risk for cardiovascular events has lessened over recent years, report researchers.
Cost drives one in six US adults to ration insulin
Findings from a nationally representative US survey show that a substantial minority of people with diabetes ration their use of insulin because of issues with affordability.
